Academic literature on the topic 'In vitro fertilization-embryo transfer'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'In vitro fertilization-embryo transfer.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "In vitro fertilization-embryo transfer"
Pace-Owens, Sylvia. "In Vitro Fertilization and Embryo Transfer." Journal of Obstetric, Gynecologic & Neonatal Nursing 14 (November 1985): S44—S48. http://dx.doi.org/10.1111/j.1552-6909.1985.tb02799.x.
Full textCoulam, Carolyn B. "In Vitro Fertilization and Embryo Transfer." Mayo Clinic Proceedings 60, no. 12 (December 1985): 893–94. http://dx.doi.org/10.1016/s0025-6196(12)64801-0.
Full textCampagnoli, C., A. Di Gregorio, R. Arisio, and L. Fessia. "In vitro fertilization and embryo transfer." Experientia 41, no. 12 (December 1985): 1491–94. http://dx.doi.org/10.1007/bf01964780.
Full textShaw, R. W. "In Vitro Fertilization and Embryo Transfer." Postgraduate Medical Journal 61, no. 719 (September 1, 1985): 847. http://dx.doi.org/10.1136/pgmj.61.719.847-a.
Full textGleicher, Norbert. "In Vitro Fertilization and Embryo Transfer." JAMA: The Journal of the American Medical Association 254, no. 20 (November 22, 1985): 2974. http://dx.doi.org/10.1001/jama.1985.03360200128050.
Full textNemiro, Jay S., and Robert W. McGaughey. "Book ReviewIn Vitro Fertilization and Embryo Transfer." New England Journal of Medicine 314, no. 8 (February 20, 1986): 525. http://dx.doi.org/10.1056/nejm198602203140826.
Full textMarmaduke, Angela, and Shirley K. Bell. "In Vitro Fertilization and Embryo Transfer Dilemmas." Nursing Forum 24, no. 3-4 (October 1989): 24–28. http://dx.doi.org/10.1111/j.1744-6198.1989.tb00826.x.
Full textElm, Laura. "Embryo Mortality and In Vitro Fertilization." Ethics & Medics 43, no. 4 (2018): 3–4. http://dx.doi.org/10.5840/em20184347.
Full textThurin, Ann, Jon Hausken, Torbjörn Hillensjö, Barbara Jablonowska, Anja Pinborg, Annika Strandell, and Christina Bergh. "Elective Single-Embryo Transfer versus Double-Embryo Transfer in in Vitro Fertilization." New England Journal of Medicine 351, no. 23 (December 2, 2004): 2392–402. http://dx.doi.org/10.1056/nejmoa041032.
Full textDrews, M. R. "Elective Single-Embryo Transfer Versus Double-Embryo Transfer in In Vitro Fertilization." Yearbook of Obstetrics, Gynecology and Women's Health 2006 (January 2006): 195–99. http://dx.doi.org/10.1016/s1090-798x(08)70429-6.
Full textDissertations / Theses on the topic "In vitro fertilization-embryo transfer"
Bruckner, Michael. "Biofluid Mechanics Of Embryo Transfer." Thesis, Lyon 1, 2013. http://www.theses.fr/2013LYO10159.
Full textThis thesis focuses on the study of the hydrodynamic behavior of an embryo during the transfer process following the in vitro fertilization. Worldwide, one in six couples experiences infertility problems. Today, 5 millions babies are born from an in-vitro fertilization since the first one in 1978. In 2009, 1.5 millions Assisted Reproductive Technology cycles have been started, resulting in 350 000 births. The total number of cycles per year is constantly increasing (from 5 to 10 %), and the number of ART cycles is believed to reach 4 millions per year in 2020. Although the fertilization step is now fairly mastered with a 80% success rate, the final stage consisting in the embryo transfer into the uterine cavity remains a critical step, since only 25% of the cycles lead to a live birth. Even though every cycle is expensive, no specific, optimized and operator-independent protocol has been developed yet. In this thesis, we first demonstrate the interest and the feasibility of a bio-engineering approach. Indeed, although the issue of the transfer depends on numerous chemical and physiological factors, this crucial step can also be studied from a fluid mechanical point of view. This step can be divided in several sub-steps : introduction of the catheter in the intra-uterine cavity, injection of the medium fluid containing one or several embryos, and the withdrawal of the catheter. One can identify several important parameters such as fluids viscosity, injections speeds, catheter withdrawal speed, catheter loading scheme and the geometries of the uterine cavity and the catheter. In a second part, we focus on the fluid ow patterns inside the uterine cavity during the injection. The influence of the system parameters is studied thanks to a computational solving of the Navier-Stokes equations in an idealized three-dimensional uterine cavity. A study of the potential trajectories of the embryos is also conducted and confronted against the location of optimal implantation zones but also risky zones. As the outcome of these computations, we are able to propose recommendations for physicians practicing embryo transfers. In the last part of the thesis, we discuss numerical methods for the fluid{structure interaction study of embryo transfer. The embryo is indeed submitted to potentially destructive stress constraints at injection time that we are not capable of defining precisely at the scale of the uterine cavity. With the aim of developing a mechanical model for the blastocyst to determine system parameters minimizing the constraints, we present the implementation of two Eulerian numerical methods. The first one is a fluid-structure level set method in a finite volume code benefiting from an automatic mesh refinement feature. The second one addresses a phase field method based on a Discontinuous Galerkin finite element formalism
Bolling, Laura Clayton. "The Effect of Growth Hormone on Pig Embryo Development in Vitro and an Evaluation of Sperm-Mediated Gene Transfer in the Pig." Thesis, Virginia Tech, 2001. http://hdl.handle.net/10919/35823.
Full textMaster of Science
Inzunza, José. "New micromanipulative techniques in reproductive biology /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-568-9/.
Full textHollinshead, Fiona Kate. "FLOW-CYTOMETRIC SORTING OF RAM SPERMATOZOA: PRODUCTION OF LAMBS OF A PRE-DETERMINED SEX USING IN VIVO AND IN VITRO FERTILISATION." University of Sydney, 2003. http://hdl.handle.net/2123/566.
Full textGaggiotti-Marre, Sofia. "Impact of serum progesterone on reproductive outcomes in frozen embryo transfer cycles." Doctoral thesis, Universitat Autònoma de Barcelona, 2021. http://hdl.handle.net/10803/672553.
Full textA pesar de que el origen de su nombre no es del todo claro, a mí me gusta pensar que la etimología de la hormona progesterona deriva de que es la hormona pro gestare, es decir, que favorece la gestación. Sabemos que esta hormona se secreta en grandes cantidades después de la ovulación y, dado el caso, durante la gestación. A su vez, es la responsable de preparar el endometrio (parte interna del útero) para recibir un embrión y lograr así un embarazo. Cuando realizamos un tratamiento de reproducción asistida, en concreto una fecundación in vitro, y no conseguimos una gestación en el primer intento o por una causa médica, en muchas ocasiones tenemos embriones congelados que podemos usar para un nuevo intento o en caso de desear otro hijo/a. En estas ocasiones, hay que decidir cómo se prepara el endometrio para recibir el embrión y conseguir la gestación. La importancia y necesidad de la progesterona en la preparación del endometrio es incuestionable. Aun así, en un primer estudio hemos encontrado que las mujeres con valores en sangre de progesterona inferiores a 10.6ng/mL el día antes de la transferencia de un embrión, presentaban más abortos (26.6% vs 9.5%) y menos nacidos vivos (47.5% vs 62.3%) respecto a aquellas con valores más elevados (Gaggiotti-Marre, 2019). Esta tendencia se mantenía tanto cuando preparábamos el endometrio con tratamiento médico hormonal como cuando seguíamos el ciclo natural de la paciente. Es decir, tanto si la progesterona la dábamos nosotros (administración vaginal cada 8 horas) como si la fabrica la mujer de forma natural (Gaggiotti-Marre, 2020). Y esto, por qué puede pasar? Descubrimos que ciertos factores eran determinantes de los valores de progesterona en sangre: edad, peso, un ciclo previo de tratamiento ya con valores bajos de progesterona, y el tiempo transcurrido desde la última administración del tratamiento (González-Foruria, 2020), con la cual cosa estos factores pueden ayudar a prever qué pacientes tiene un mayor riesgo de tener unos niveles bajos de progesterona y unos peores resultados reproductivos. Nos queda entonces encontrar una solución a este hallazgo que hace que las parejas tengan más abortos y menos nacidos vivos. Diseñamos un estudio prospectivo por el cual las mujeres con valores bajos de progesterona el día antes de transferir un embrión recibían una dosis diaria de progesterona con formulación subcutánea de reciente aparición en el mercado. De las 453 pacientes incluidas en el estudio, un 37.7% presentaban valores bajos de progesterona. De las que recibieron el tratamiento adicional, el 98.2% llegaron a valores óptimos, obteniendo los mismos resultados reproductivos (nacidos vivos y abortos) que aquellas pacientes que inicialmente ya presentaban unos valores elevados (Álvarez, 2021). En conclusión, la detección de valores de progesterona en sangre inferiores a 10.6ng/mL el día antes de la transferencia de embriones congelados se relaciones con menores tasas de nacidos vivos y más abortos, pero es un hallazgos corregible si se detecta con tiempo. Esto nos permite ofrecer un tratamiento individualizado y así continual el camino hacia una medicina personalizada y no un tratamiento ‘one size fits all’.
Although its origin is not clear, I like to think that the etymology of the hormone progesterone comes from it being the hormone pro gestare, which favors the gestation. We know that this hormone is secreted in great quantities after ovulation, and specially in case of a pregnancy. Also, it is responsible for preparing the endometrium (inner lining of the uterus) to receive an embryo and accomplish a viable pregnancy. When we perform an assisted reproduction treatment, specifically an in vitro fertilization and we don’t achieve a pregnancy on the first trial, or for other medical reasons, we may have frozen embryos that we can transfer. In these cases, we need to decide how to prepare the endometrium to receive these embryos and achieve a pregnancy. The importance and need of progesterone for the endometrial preparation is unquestionable. Even though, on a first publication we found that women with serum progesterone levels below 10.6ng/mL the day prior to embryo transfer, presented higher miscarriage rates (26.6% vs 9.5%) and lower live birth rates (47.5% vs 62.3%) compared to those with higher values (Gaggiotti-Marre, 2019). This tendency was maintained both with medical preparation of the endometrium and without any treatment (natural cycle) (Gaggiotti-Marre, 2020). Y why does this happen? We found that certain factors were determinant of the serum progesterone levels: age, weight, a previous cycle with low serum progesterone, and the time from the last administered dose of progesterone (González-Foruria, 2020). This indicates that these factors can help detect those patients at a higher risk for low serum progesterone levels and detrimental reproductive outcomes. We need then to find a solution for this finding that makes that couples have more miscarriages and fewer living children. We designed a prospective study in which women with low serum progesterone levels on the day prior to frozen embryo transfer received an additional daily dose of subcutaneous progesterone. Of the 453 women included in the study, 37.7% had low serum progesterone levels. From those who received an additional dosage, 98.2% reached optimal levels, with similar reproductive outcomes to those with original optimal levels. (Álvarez, 2021). In conclusion, the detection of low serum progesterone levels, below 10.6ng/mL the day prior to frozen embryo transfer, is related to lower live birth rates and higher miscarriage rates, but this finding is correctable when detected in time. This allows us to offer an individualized treatment and continue working towards a personalized medicine in stead of a ‘one size fits all’ approach.
Universitat Autònoma de Barcelona. Programa de Doctorat en Pediatria, Obstetrícia i Ginecologia
Skoog, Svanberg Agneta. "The Long and Winding Road : Emotional Reactions during In Vitro Fertilization and Attitudes towards Cryopreserved Embryos and Oocyte Donation." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2003. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3733.
Full textJones, Christopher A. "Economic evaluation of alternative embryo transfer policies in in vitro fertilisation (IVF)." Thesis, University of Oxford, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426399.
Full textSharma, Vinay. "Endocrine and non-endocrine factors affecting the outcome of assisted conception." Thesis, King's College London (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.244126.
Full textWirtu, Gemechu G. "Xenogenous Intrafallopian Transfer of Horse (Equus caballus) Gametes." Thesis, Virginia Tech, 1999. http://hdl.handle.net/10919/34626.
Full textMaster of Science
Rosado, Marcelo Milagres. "Uso de protocolo de sincronização de estro em receptoras mestiças inovuladas com embriões in vitro." Universidade Federal de Viçosa, 2010. http://locus.ufv.br/handle/123456789/5123.
Full textAiming to study the effect of different estrus synchronization protocols on the pregnancy rate in Bos taurus indicus x Bos taurus taurus recipient cattles, transferred with in vitro produced embryos, this study used 1,933 recipients (3,649 treatments) divided into 6 groups. In the first group, recipients received 2.0 mg of estradiol benzoate (EB) and 500 mg of cloprostenol, in addiction to an intravaginal device (1.9 g of progesterone) that remained for 8 days. Upon withdrawal of the intravaginal device each recipient received a single dose of 0.5 mg of estradiol cypionate (EC), 500 mg of cloprostenol and 400 IU of equine chorionic gonadotropin (eCG). In the second group, recipients received the same treatment as the first group, but without the 500 mg dose of cloprostenol at the placement of the progesterone intravaginal device. In the third group, recipients received at the time of intravaginal progesterone device placement a single dose of 500 mg cloprostenol and 2.0 mg of EB, and the device remained for 9 days. Two days before the intravaginal device removal (day 7) females received a single dose of 500 mg cloprostenol, and at the time of device removal, received a single dose of 0.5 mg of EC and 400 IU of eCG. In the fourth group, the recipients received the same treatment as the third group, but without cloprostenol in the intravaginal progesterone device placement. In the fifth group, recipients received 2.0 mg of EB, and an intravaginal progesterone device that remained for 8 days. Upon withdrawal of the intravaginal device, each recipient received 0.5 mg of EC, 500 mg of cloprostenol and 300 IU of eCG. In the sixth group, recipie nts received 2.0 mg of EB and an intravaginal progesterone device for 9 days. Two days before the withdrawal, (day 7), received 500 mg of cloprostenol and at the time of device removal received 0.5 mg of EC and 300 IU of eCG. All recipients that had corpus luteum were transferred on average 10 days after implant removal, in other words, about 8 days after estrus, and evaluated by ultrasonography 58 days after embryo transfer to pregnancy diagnosis. Data were subjected to descriptive statistics analysis (means, standard deviations and frequency distribution) and qualitative data were arranged in contingency tables and analyzed by chi-square at 5% of probability. Fourth group showed the best recovery rates (84.9%). However, the number of treatments performed (n=86) in group 4 was reduced in comparison with other protocols. Recipients who received Prostaglandin F2α (PGF2α) 48 hours before device removal showed better recovery rates than others and protocol 4 females had better pregnancy rates. The recipients that were in estrus longer than 91 days before device placing had worse recovery rates than recipients in estrus earlier (p<0.05), although did not influence pregnancy rate (p>0.05) . Despite some recipients peculiarities who presented estrus less than 16 days, the interval form estrus day to device placement did not influence positively these assessments (p>0.05). The uterus classified as normal in protocol 4 showed the best percentages of recovering and pregnancy rates (p<0.05) compared to the values of other protocols. However, comparing all protocols, the uterus classified as flaccid showed better recovery responses and classification did not influence uterine pregnancy rate. As the ovarian activity, the presence of corpus luteum influenced recipients recovery rates (p<0.05), whereas the follicles presence only interfered with the pregnancy rate of protocol 4 animals (p<0.05). The number of uses of the device did not influence the recipients recovery pregnancy rates (p>0.05). The reproductive status and protocol number in the history did not affect the recipients recovery rate (p>0.05). However, recipients who did not received PGF2α before intravaginal device placing, had better results than those who received (p<0.05). The recipients which were transferred with expanded blastocyst had better pregnancy rates than they which were transferred with blastocyst (p<0.05). No differences were found in the cow and heifer categories in recipient donor estrus synchrony in relation to pregnancy rate (p>0.05). No influence of the time trial on the pregnancy rate (p>0.05). The protocols which employed PGF2α 48 hours before the withdrawal had better recipients recovery rates than the protocols that applications were made on intravaginal device removal (p<0.05). Protocol 4 recipients had higher pregnancy rates, although it was a group of low numbers of animals. The used protocols interfered with the recipients recovery rate, and the applications of PGF2α 48 hours before intravaginal device removal, resulted in improved estrus synchronization responses, so the answer was more pronounced when females were cyclical in occasion of the beginning of synchronization; intervals from the last estrus to intravaginal device placement over 90 days (anestrus) influence negatively the responses to estrus and ovulation synchronization protocols. However, the classes of interval from estrus to intravaginal device placement (CLAPROT), the covariates showed no marked effect on the recipients recovery response; The female categories (cows and heifers) did not influence the responses to estrus synchronization treatments, although heifers in the pre-puberty are less responsive to PGF2α application in the beginning of the protocol. Regardless of the females category, the presence of the corpus luteum and flaccid uterine tone at the time of intravaginal device placement proved to be positively related to the recipients recovery response; Reusing intravaginal device has no influence on the recovery and pregnancy rates in embryo recipients; Females with histories of prior use of synchronization protocols with the use of PGF2α become less responsive to new synchronization protocols, while not presenting the same behavior with respect to protocols with progesterone associated with PGF2α.
Com o objetivo de estudar o efeito de diferentes protocolos de sincronização de estro (Uso de cloprostenol no momento da colocação do implante intravaginal e sua permanência por período de oito e nove dias) sobre a taxa de prenhez em receptoras bovinas Bos taurus indicus x Bos taurus taurus, inovuladas com embriões de PIV, o presente estudo utilizou 1933 receptoras (3.649 tratamentos) divididas em 6 protocolos. No protocolo 1, as receptoras receberam 2,0 mg de Benzoato de estradiol (BE) e 500 μg de cloprostenol, e um dispositivo intravaginal (1,9 g de Progesterona) que permaneceu por 8 dias. No momento da retirada do dispositivo intravaginal cada receptora recebeu uma dose única de 0,5 mg de Cipionato de estradiol (CE), 500 μg de Cloprostenol e 400 UI de gonadotrofina coriônica eqüina (eCG). No protocolo 2, as receptoras receberam o mesmo tratamento que o primeiro grupo, porém sem a dose de 500 μg de Cloprostenol na colocação do dispositivo intravaginal de progesterona. No protocolo 3, as receptoras receberam no momento da colocação do dispositivo intravaginal de progesterona uma dose única de 500 μg de Cloprostenol e 2,0 mg de BE, sendo que o dispositivo permaneceu por 9 dias. Dois dias antes da retirada do dispositivo intravaginal (dia 7) as fêmeas receberam uma dose única de 500 μg de Cloprostenol, e no momento da retirada do implante, receberam uma dose única de 0,5 mg de CE e 400 UI de eCG. No protocolo 4, as receptoras receberam o mesmo tratamento que o protocolo 3, porém sem Cloprostenol na colocação do dispositivo intravaginal de progesterona. No protocolo 5, as receptoras receberam 2,0 mg de Benzoato de estradiol, e um dispositivo intravaginal de progesterona por 9 dias. Dois dias antes da retirada, no dia 7, receberam 500 μg de Cloprostenol e no momento da retirada do implante 0,5mg de CE e 300 UI de eCG. No protocolo 6, as receptoras receberam 2,0 mg de BE, e um dispositivo intravaginal de progesterona que permaneceu por 8 dias. No momento da retirada do dispositivo intravaginal, cada receptora recebeu 0,5 mg de CE, 500 μg de Cloprostenol e 300 UI de eCG. Todas as receptoras que apresentaram corpo lúteo foram inovuladas em média 10 dias após a retirada do dispositivo, ou seja, por volta de 8 dias após estro; e avaliadas por meio de ultrassonografia aos 58 dias após inovulação para o diagnóstico de gestação. Os dados foram submetidos a análises estatísticas descritivas (distribuição de freqüência) e os dados qualitativos foram arranjados em tabelas de contingência e analisados pelo teste de qui-quadrado a 5 % de probabilidade de erro. As receptoras do quarto protocolo apresentaram as melhores (p<0,05) taxas de aproveitamento (84,9%). No entanto, o número de tratamentos realizados (n=86) para o protocolo 4 foi reduzido em relação aos demais protocolos, mais estudos tornam-se necessários para confirmar a eficácia desse protocolo. Receptoras que receberam PGF2α 48 horas antes da retirada do dispositivo apresentaram melhores índices de aproveitamento de receptoras (p<0,05) e as fêmeas do protocolo 4 apresentaram melhores índices de prenhez (p<0,05). As receptoras que apresentaram estro em período superior a 91 dias antes da colocação do dispositivo apresentaram piores taxas de aproveitamento que receptoras que apresentaram estro mais recente (p<0,05). Apesar de algumas particularidades das receptoras que apresentaram estro em período inferior a 16 dias, o intervalo dia do estro a colocação do implante não influenciou positivamente nessas avaliações (p>0,05). O útero classificado como normal no protocolo 4 foi o que apresentou melhores valores percentuais de taxa de aproveitamento e de prenhez em relação aos valores dos demais protocolos (p<0,05). Entretanto, comparando todos os protocolos, o útero classificado como flácido apresentou melhores respostas de aproveitamento de receptoras (p>0,05) e a classificação uterina não influenciou a taxa de prenhez (p>0,05). Quanto a atividade ovariana, a presença do CL influenciou na taxa de aproveitamento de receptoras (p<0,05), já a presença de folículos só interferiu na taxa de prenhez dos animais do protocolo 4 (p<0,05). O número de utilização do dispositivo não influenciou na taxa de aproveitamento de receptoras e na taxa de prenhez (p>0,05). O status reprodutivo e o número de protocolo no histórico não interferiram na taxa de aproveitamento de receptoras (p>0,05). No entanto, receptoras que não receberam PGF2α antes da colocação do dispositivo intravaginal, apresentaram melhores resultados que as receptoras que receberam PGF2α (p<0,05). As receptoras que foram inovuladas com blastocisto expandido apresentaram melhores taxas de prenhez do que as receptoras que foram inovuladas com blastocisto (p<0,05). Não houve diferença nas categorias vacas e novilhas na sincronia do estro receptora doadora, em relação à taxa de prenhez (P>0,05). Não houve influência da época experimental sobre a taxa de prenhez (p>0,05). Os protocolos que empregaram PGF2α 48 horas antes da retirada apresentaram melhores taxas de aproveitamento de receptoras do que os protocolos em que as aplicações foram feitas no momento da retirada do dispositivo intravaginal (p<0,05). As receptoras do protocolo 4 apresentaram melhores taxas de prenhez, embora tenha sido um grupo de baixo número de animais. Os protocolos utilizados interferiram na taxa de aproveitamento de receptoras, sendo que, as aplicações de PGF2α 48 horas antes da retirada do dispositivo intravaginal, resultaram em melhores respostas de sincronização de estro, sendo a resposta mais acentuada quando as fêmeas estavam cíclicas na ocasião do início das sincronizações; Os intervalos do ultimo estro à colocação do dispositivo intravaginal superiores a 90 dias (anestro) influenciam negativamente as respostas aos protocolos de sincronização de estro de ovulaç ão. No entanto, as classes de intervalo do estro à colocação do dispositivo intravaginal (CLAPROT), as co-variáveis estudadas não apresentaram efeito marcante sobre a resposta de aproveitamento de receptoras; As categorias de fêmeas (vacas e novilhas) não influenciam a respostas aos tratamentos de sincronização de estro (p>0,05), embora novilhas na fase pré-puberal são menos responsivas a aplicação de PGF2α no início do protocolo. Independente da categoria de fêmeas, a presença do corpo lúteo e tonicidade uterina flácida no momento da colocação do dispositivo intravaginal mostraram-se positivamente relacionado à resposta de aproveitamento de receptoras; A reutilização de dispositivo intr avaginal não apresenta influencia sobre a taxa de aproveitamento e prenhez em receptoras de embriões; Fêmeas com históricos prévios de uso de protocolos de sincronização com uso de PGF2α a apresentam-se menos responsíveis a novos protocolos de sincronização, embora não apresentam o mesmo comportamento com relação aos protocolos com progestagenos associado a PGF2α.
Books on the topic "In vitro fertilization-embryo transfer"
Wisconsin), Workshop on Laboratory Techniques in In Vitro Fertilization and Embryo Culture (2nd 1985 University of. In vitro fertilization and embryo transfer. New York: Plenum, 1988.
Find full textWolf, Don P., Barry D. Bavister, Marybeth Gerrity, and Gregory S. Kopf, eds. In Vitro Fertilization and Embryo Transfer. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1005-1.
Full textWolf, Don P., Richard L. Stouffer, and Robert M. Brenner, eds. In Vitro Fertilization and Embryo Transfer in Primates. New York, NY: Springer New York, 1993. http://dx.doi.org/10.1007/978-1-4612-2716-8.
Full textTest tube babies: In vitro fertilization and embryo transfer. Phoenix, Ariz: Oryx Press, 1986.
Find full textWisconsin--Extension), Workshop on Laboratory Techniques in In Vitro Fertilization and Embryo Culture (2nd 1985 University of. In vitro fertilization and embryo transfer: A manual of basic techniques. New York: Plenum Press, 1988.
Find full textWu, Bin. Advances in embryo transfer. Rijeka: InTech, 2012.
Find full textCarl, Wood, and Trounson Alan, eds. Clinical in vitro fertilization. 2nd ed. London: Springer-Verlag, 1989.
Find full textJacques, Testart, Frydman René, and Institut national de la santé de la recherche médicale (France), eds. Human in vitro fertilization: Actual problems and prospects : proceedings of the International Symposium on Human In Vitro Fertilization held in Cargèse (France), 19-22 September 1984. Amsterdam: Elsevier Science Publishers, 1985.
Find full textGreat Britain. Human Fertilisation & Embryology Authority. Statutory storage period for embryos: Report by the Human Fertilisation & Embryology Authority to the Health Ministers of the United Kingdom. London]: Dept. of Health, 1995.
Find full text1925-, Edwards R. G., Purdy Jean M, and Steptoe Patrick Christopher, eds. Implantation of the human embryo: Proceedings of the second Bourn Hall meeting. London: Academic Press, 1985.
Find full textBook chapters on the topic "In vitro fertilization-embryo transfer"
Gerrity, Marybeth, and John S. Rinehart. "Embryo Transfer." In In Vitro Fertilization and Embryo Transfer, 189–206. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1005-1_11.
Full textHardarson, Thorir, and Matts Wikland. "Single Embryo Transfer." In In Vitro Fertilization, 729–33. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-43011-9_60.
Full textMariani, Giulia, and José Bellver. "Embryo Transfer." In Handbook of In Vitro Fertilization, 331–42. Taylor & Francis Group, 6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL 33487-2742: CRC Press, 2017. http://dx.doi.org/10.1201/9781315157269-22.
Full textBhattacharyya, Jutimala, Sankalp Singh, Madhab C. Das, and Kanna Jayaprakasan. "Embryo Transfer: Techniques and Troubleshooting." In In Vitro Fertilization, 735–49. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-43011-9_61.
Full textBarton, Sara E., and Elizabeth S. Ginsburg. "Oocyte Retrieval and Embryo Transfer." In In Vitro Fertilization, 55–74. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-9848-4_4.
Full textRichter, Kevin S., Robert J. Stillman, and Eric A. Widra. "Moving Toward Single Embryo Transfer." In In Vitro Fertilization, 75–82. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-9848-4_5.
Full textByrd, William. "Gamete Intrafallopian Transfer (GIFT)." In In Vitro Fertilization and Embryo Transfer, 265–84. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1005-1_14.
Full textGerrity, Marybeth. "Mouse Embryo Culture Bioassay." In In Vitro Fertilization and Embryo Transfer, 57–76. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1005-1_5.
Full textChopra, Mani, Muskan Budhwar, Madhu Sharma, and Ranbir Chandra Sobti. "In Vitro Fertilization and Embryo Transfer." In Biodiversity, 309–24. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003220398-20.
Full textWolf, Don P. "Analysis of Oocyte Quality and Fertilization." In In Vitro Fertilization and Embryo Transfer, 125–36. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-1005-1_8.
Full textConference papers on the topic "In vitro fertilization-embryo transfer"
Agung Christianto, Paminto, Eko Sediyono, and Irwan Sembiring. "Case-Based Reasoning Modifications for Intelligent Systems in Handling In Vitro Fertilization (IVF) Patients Post Embryo Transfer." In 2020 International Seminar on Application for Technology of Information and Communication (iSemantic). IEEE, 2020. http://dx.doi.org/10.1109/isemantic50169.2020.9234270.
Full textLian, F., J. Zhou, Y. Wang, H. Xu, and X. Yang. "FRI0338 Hydroxychloroquine may help to improve the in vitro fertilization-embryo transfer outcomes in ana and ds-dna positive patients." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.1626.
Full textTakayama, Shuichi, Yi-Chung Tung, and Bor-Han Chueh. "Biological Micro/Nanofluidics." In ASME 2008 First International Conference on Micro/Nanoscale Heat Transfer. ASMEDC, 2008. http://dx.doi.org/10.1115/mnht2008-52087.
Full textSamie Dehkordi, Kimiya, and Mohsen Ebrahimi Moghaddam. "The Detection of Blastocyst Embryo In Vitro Fertilization (IVF)." In 2022 12th Iranian/Second International Conference on Machine Vision and Image Processing (MVIP). IEEE, 2022. http://dx.doi.org/10.1109/mvip53647.2022.9738768.
Full textKandel, Mikhail E., Marcello Rubessa, Daniel Fernandes, Tan H. Nguyen, Matthew B. Wheeler, and Gabriel Popescu. "Monitoring in-vitro bovine embryo development during the first days after fertilization (Conference Presentation)." In Quantitative Phase Imaging II, edited by Gabriel Popescu and YongKeun Park. SPIE, 2016. http://dx.doi.org/10.1117/12.2217122.
Full textLestari, Silvia W., Aucky Hinting, Hamdani Lunardi, Debby Aditya, Dessy Noor Miati, and Meidika Dara Rizki. "Sperm Na+,K+-ATPase and dynein ATPase activity: A study of embryo development in in vitro fertilization (IVF)." In SECOND INTERNATIONAL CONFERENCE OF MATHEMATICS (SICME2019). Author(s), 2019. http://dx.doi.org/10.1063/1.5096752.
Full textWahyuni, Alfaina. "The Outcomes of Invitro Fertilization and Embryo Transfer in Endometriosis-Associated Infertility: A Case Control Study." In Proceedings of the Third International Conference on Sustainable Innovation 2019 – Health Science and Nursing (IcoSIHSN 2019). Paris, France: Atlantis Press, 2019. http://dx.doi.org/10.2991/icosihsn-19.2019.10.
Full textAl-Ansari, Dana E., Nura A. Mohamed, Isra Marei, Huseyin Yalcin, and Haissam Abou-Saleh. "Assessment of Metal Organic Framework as Potential Drug Carriers in Cardiovascular Diseases." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0127.
Full textReports on the topic "In vitro fertilization-embryo transfer"
Hansen, Peter J., and Amir Arav. Embryo transfer as a tool for improving fertility of heat-stressed dairy cattle. United States Department of Agriculture, September 2007. http://dx.doi.org/10.32747/2007.7587730.bard.
Full textPetitte, James, Hefzibah Eyal-Giladi, and Malka Ginsburg. The Study of Primordial Germ Cell Development as a Tool for Gene Transfer in Chickens. United States Department of Agriculture, October 1991. http://dx.doi.org/10.32747/1991.7561071.bard.
Full textAdelberg, Jeff, Halina Skorupska, Bill Rhodes, Yigal Cohen, and Rafael Perl-Treves. Interploid Hybridization of Cucumis melo and C. metuliferus. United States Department of Agriculture, December 1999. http://dx.doi.org/10.32747/1999.7580673.bard.
Full textWolfenson, David, William W. Thatcher, Rina Meidan, Charles R. Staples, and Israel Flamenbaum. Hormonal and Nutritional Stretegies to Optimize Reproductive Function and Improve Fertility of Dairy Cattle during Heat Stress in Summer. United States Department of Agriculture, August 1994. http://dx.doi.org/10.32747/1994.7568773.bard.
Full textOhad, Nir, and Robert Fischer. Regulation of Fertilization-Independent Endosperm Development by Polycomb Proteins. United States Department of Agriculture, January 2004. http://dx.doi.org/10.32747/2004.7695869.bard.
Full text